CSS LLC’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-38,848
Closed -$2.04K 1059
2025
Q3
$2.04K Hold
38,848
﹤0.01% 981
2025
Q2
$2.21K Hold
38,848
﹤0.01% 949
2025
Q1
$839 Hold
38,848
﹤0.01% 905
2024
Q4
$1.71K Hold
38,848
﹤0.01% 947
2024
Q3
$1.17K Hold
38,848
﹤0.01% 810
2024
Q2
$2.32K Hold
38,848
﹤0.01% 859
2024
Q1
$1.98K Hold
38,848
﹤0.01% 793
2023
Q4
$2.41K Sell
38,848
-34,900
-47% -$1.37K ﹤0.01% 778
2023
Q3
$3.33K Hold
73,748
﹤0.01% 788
2023
Q2
$10.6K Hold
73,748
﹤0.01% 835
2023
Q1
$21.7K Hold
73,748
﹤0.01% 638
2022
Q4
$14.7K Buy
73,748
+57,512
+354% +$3.84K ﹤0.01% 800
2022
Q3
$1K Hold
16,236
﹤0.01% 1031
2022
Q2
$1K Buy
+16,236
New +$1.22K ﹤0.01% 1090
2022
Q1
Sell
-10,268
Closed -$7K 1186
2021
Q4
$7K Hold
10,268
﹤0.01% 1215
2021
Q3
$5K Buy
+10,268
New +$3.9K ﹤0.01% 1161

Other funds holding COEPW

CSS LLC's COEPW Position: Q4 2025 in Review

CSS LLC sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2025, closing a stake of 38,848 shares — an estimated $2.04K sold.

CSS LLC first reported a position in COEPW in Q3 2021 and held it in 16 quarters. The position peaked at $21.7K in Q1 2023. 11 funds tracked by Wall St. Rank hold COEPW as of Q4 2025.

  • CSS LLC reported no remaining Coeptis Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • CSS LLC sold 38,848 Coeptis Therapeutics Warrants shares in Q4 2025, an estimated $2.04K.
  • CSS LLC first reported a position in Coeptis Therapeutics Warrants in Q3 2021 and held it in 16 quarters.
  • CSS LLC's Coeptis Therapeutics Warrants position peaked at $21.7K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2025.

Based on CSS LLC's 13F filing for Q4 2025, filed 17 Feb 2026.